Elisa Carrió, the leader of the Civic Coalition party in Argentina, recently expressed her support for the actions of Federico Sturzenegger, the Minister of Deregulation and State Transformation. Carrió praised the Joint Resolution 1/2026, which removes existing restrictions on obtaining pharmaceutical patents. This move is seen as a significant step towards enhancing competition and allowing the importation of foreign pharmaceuticals, aiming to improve accessibility and lower drug costs for Argentine citizens.

In her remarks, shared through her social media account on X, Carrió highlighted that the changes proposed by Sturzenegger stand in stark contrast to the ongoing criticisms she has for President Javier Milei's administration. She emphasized the importance of fostering a conducive environment for foreign pharmaceutical companies to contribute to the market, which could alleviate the burden of high drug prices burdening the Argentine public.

The implications of this resolution are profound for the Argentine healthcare system. By dismantling the protective measures that had been in place for local laboratories, the government appears to be taking steps towards a more liberalized economy. This could lead to a wider array of medication availability for citizens, however, it might also incite opposition from local pharmaceutical producers who may face increased competition from foreign entities. Carrió's support suggests a fracture in the political landscape, as different factions respond to the ramifications of Sturzenegger's policy changes.